-
1
-
-
0020660717
-
Two pathogenetic types of endometrial carcinoma
-
10.1016/0090-8258(83)90111-7, 6822361
-
Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983, 15:10-17. 10.1016/0090-8258(83)90111-7, 6822361.
-
(1983)
Gynecol Oncol
, vol.15
, pp. 10-17
-
-
Bokhman, J.V.1
-
2
-
-
84877254190
-
Integrated genomic characterization of endometrial carcinoma
-
10.1038/nature12113, 3704730, 23636398, Cancer Genome Atlas Research Network
-
Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA, Cancer Genome Atlas Research Network Integrated genomic characterization of endometrial carcinoma. Nature 2013, 497:67-73. 10.1038/nature12113, 3704730, 23636398, Cancer Genome Atlas Research Network.
-
(2013)
Nature
, vol.497
, pp. 67-73
-
-
Kandoth, C.1
Schultz, N.2
Cherniack, A.D.3
Akbani, R.4
Liu, Y.5
Shen, H.6
Robertson, A.G.7
Pashtan, I.8
Shen, R.9
Benz, C.C.10
Yau, C.11
Laird, P.W.12
Ding, L.13
Zhang, W.14
Mills, G.B.15
Kucherlapati, R.16
Mardis, E.R.17
Levine, D.A.18
-
3
-
-
33646934663
-
Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies
-
10.1016/j.critrevonc.2005.11.002, 16436330
-
Gadducci A, Cosio S, Genazzani AR. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies. Crit Rev Oncol Hematol 2006, 58:242-256. 10.1016/j.critrevonc.2005.11.002, 16436330.
-
(2006)
Crit Rev Oncol Hematol
, vol.58
, pp. 242-256
-
-
Gadducci, A.1
Cosio, S.2
Genazzani, A.R.3
-
4
-
-
0036114217
-
Expression of androgen receptor and 5α-reductases in the human normal endometrium and it's disorders
-
10.1002/ijc.10394, 12115497
-
Ito K, Suzuki T, Akahira J, Moriya T, Kaneko C, Utsunomiya H, Yaegashi N, Okamura K, Sasano H. Expression of androgen receptor and 5α-reductases in the human normal endometrium and it's disorders. Int J Cancer 2002, 99:652-657. 10.1002/ijc.10394, 12115497.
-
(2002)
Int J Cancer
, vol.99
, pp. 652-657
-
-
Ito, K.1
Suzuki, T.2
Akahira, J.3
Moriya, T.4
Kaneko, C.5
Utsunomiya, H.6
Yaegashi, N.7
Okamura, K.8
Sasano, H.9
-
5
-
-
0027067052
-
Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium
-
Horie K, Takakura K, Imai K, Liao S, Mori T. Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium. Hum Reprod 1992, 7:1461-1466.
-
(1992)
Hum Reprod
, vol.7
, pp. 1461-1466
-
-
Horie, K.1
Takakura, K.2
Imai, K.3
Liao, S.4
Mori, T.5
-
6
-
-
3843142677
-
Subfertility and defective folliculogenesis in female mice lacking androgen receptor
-
10.1073/pnas.0404372101, 509185, 15277682
-
Hu YC, Wang PH, Yeh S, Wang RS, Xie C, Xu Q, Zhou X, Chao HT, Tsai MY, Chang C. Subfertility and defective folliculogenesis in female mice lacking androgen receptor. Proc Natl Acad Sci USA 2004, 101:11209-11214. 10.1073/pnas.0404372101, 509185, 15277682.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 11209-11214
-
-
Hu, Y.C.1
Wang, P.H.2
Yeh, S.3
Wang, R.S.4
Xie, C.5
Xu, Q.6
Zhou, X.7
Chao, H.T.8
Tsai, M.Y.9
Chang, C.10
-
7
-
-
0036387193
-
Forkhead transcription factors: key players in development and metabolism
-
10.1006/dbio.2002.0780, 12297093
-
Carlsson P, Mahlapuu M. Forkhead transcription factors: key players in development and metabolism. Dev Biol 2002, 250:1-23. 10.1006/dbio.2002.0780, 12297093.
-
(2002)
Dev Biol
, vol.250
, pp. 1-23
-
-
Carlsson, P.1
Mahlapuu, M.2
-
8
-
-
77956649260
-
The FoxA factors in organogenesis and differentiation
-
10.1016/j.gde.2010.06.005, 2943037, 20591647
-
Kaestner KH. The FoxA factors in organogenesis and differentiation. Curr Opin Genet Dev 2010, 20:527-532. 10.1016/j.gde.2010.06.005, 2943037, 20591647.
-
(2010)
Curr Opin Genet Dev
, vol.20
, pp. 527-532
-
-
Kaestner, K.H.1
-
9
-
-
40849085514
-
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription
-
10.1016/j.cell.2008.01.018, 2323438, 18358809
-
Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS, Brown M. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 2008, 132:958-970. 10.1016/j.cell.2008.01.018, 2323438, 18358809.
-
(2008)
Cell
, vol.132
, pp. 958-970
-
-
Lupien, M.1
Eeckhoute, J.2
Meyer, C.A.3
Wang, Q.4
Zhang, Y.5
Li, W.6
Carroll, J.S.7
Liu, X.S.8
Brown, M.9
-
10
-
-
0042266417
-
The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes
-
10.1210/me.2003-0020, 12750453
-
Gao N, Zhang J, Rao MA, Case TC, Mirosevich J, Wang Y, Jin R, Gupta A, Rennie PS, Matusik RJ. The role of hepatocyte nuclear factor-3 alpha (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol Endocrinol 2003, 17:1484-1507. 10.1210/me.2003-0020, 12750453.
-
(2003)
Mol Endocrinol
, vol.17
, pp. 1484-1507
-
-
Gao, N.1
Zhang, J.2
Rao, M.A.3
Case, T.C.4
Mirosevich, J.5
Wang, Y.6
Jin, R.7
Gupta, A.8
Rennie, P.S.9
Matusik, R.J.10
-
11
-
-
80053610846
-
Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
-
10.1038/emboj.2011.328, 3209787, 21915096
-
Sahu B, Laakso M, Ovaska K, Mirtti T, Lundin J, Rannikko A, Sankila A, Turunen JP, Lundin M, Konsti J, Vesterinen T, Nordling S, Kallioniemi O, Hautaniemi S, Jänne OA. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J 2011, 30:3962-3976. 10.1038/emboj.2011.328, 3209787, 21915096.
-
(2011)
EMBO J
, vol.30
, pp. 3962-3976
-
-
Sahu, B.1
Laakso, M.2
Ovaska, K.3
Mirtti, T.4
Lundin, J.5
Rannikko, A.6
Sankila, A.7
Turunen, J.P.8
Lundin, M.9
Konsti, J.10
Vesterinen, T.11
Nordling, S.12
Kallioniemi, O.13
Hautaniemi, S.14
Jänne, O.A.15
-
12
-
-
79961029891
-
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
-
10.1038/emboj.2011.216, 3160190, 21701558
-
Robinson JL, Macarthur S, Ross-Innes CS, Tilley WD, Neal DE, Mills IG, Carroll JS. Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J 2011, 30:3019-3027. 10.1038/emboj.2011.216, 3160190, 21701558.
-
(2011)
EMBO J
, vol.30
, pp. 3019-3027
-
-
Robinson, J.L.1
Macarthur, S.2
Ross-Innes, C.S.3
Tilley, W.D.4
Neal, D.E.5
Mills, I.G.6
Carroll, J.S.7
-
13
-
-
3342986584
-
Notch signaling and cancer: emerging complexity
-
10.1016/j.semcancer.2004.04.010, 15288256
-
Axelson H. Notch signaling and cancer: emerging complexity. Semin Cancer Biol 2004, 14:317-319. 10.1016/j.semcancer.2004.04.010, 15288256.
-
(2004)
Semin Cancer Biol
, vol.14
, pp. 317-319
-
-
Axelson, H.1
-
14
-
-
73949094187
-
Role of Notch signaling in colorectal cancer
-
10.1093/carcin/bgp236, 19793799
-
Qiao L, Wong BC. Role of Notch signaling in colorectal cancer. Carcinogenesis 2009, 30:1979-1986. 10.1093/carcin/bgp236, 19793799.
-
(2009)
Carcinogenesis
, vol.30
, pp. 1979-1986
-
-
Qiao, L.1
Wong, B.C.2
-
15
-
-
67651039809
-
Notch signaling pathway in ovarian cancer
-
10.1111/IGC.0b013e3181a12ed2, 19509550
-
Rose SL. Notch signaling pathway in ovarian cancer. Int J Gynecol Cancer 2009, 19:564-566. 10.1111/IGC.0b013e3181a12ed2, 19509550.
-
(2009)
Int J Gynecol Cancer
, vol.19
, pp. 564-566
-
-
Rose, S.L.1
-
16
-
-
0033535504
-
A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain
-
10.1038/19083, 10206645
-
De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 1999, 398:518-522. 10.1038/19083, 10206645.
-
(1999)
Nature
, vol.398
, pp. 518-522
-
-
De Strooper, B.1
Annaert, W.2
Cupers, P.3
Saftig, P.4
Craessaerts, K.5
Mumm, J.S.6
Schroeter, E.H.7
Schrijvers, V.8
Wolfe, M.S.9
Ray, W.J.10
Goate, A.11
Kopan, R.12
-
17
-
-
84862912924
-
Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation
-
Wei Y, Zhang Z, Liao H, Wu L, Wu X, Zhou D, Xi X, Zhu Y, Feng Y. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation. Oncol Rep 2012, 27:504-510.
-
(2012)
Oncol Rep
, vol.27
, pp. 504-510
-
-
Wei, Y.1
Zhang, Z.2
Liao, H.3
Wu, L.4
Wu, X.5
Zhou, D.6
Xi, X.7
Zhu, Y.8
Feng, Y.9
-
18
-
-
84889766586
-
A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells
-
10.1186/1476-4598-12-155, 3879200, 24321270
-
Bao W, Wang HH, Tian FJ, He XY, Qiu MT, Wang JY, Zhang HJ, Wang LH, Wan XP. A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells. Mol Cancer 2013, 12:155. 10.1186/1476-4598-12-155, 3879200, 24321270.
-
(2013)
Mol Cancer
, vol.12
, pp. 155
-
-
Bao, W.1
Wang, H.H.2
Tian, F.J.3
He, X.Y.4
Qiu, M.T.5
Wang, J.Y.6
Zhang, H.J.7
Wang, L.H.8
Wan, X.P.9
-
19
-
-
84876217788
-
Amplitude modulation of androgen signaling by c-MYC
-
10.1101/gad.209569.112, 3639415, 23530127
-
Ni M, Chen Y, Fei T, Li D, Lim E, Liu XS, Brown M. Amplitude modulation of androgen signaling by c-MYC. Genes Dev 2013, 27:734-748. 10.1101/gad.209569.112, 3639415, 23530127.
-
(2013)
Genes Dev
, vol.27
, pp. 734-748
-
-
Ni, M.1
Chen, Y.2
Fei, T.3
Li, D.4
Lim, E.5
Liu, X.S.6
Brown, M.7
-
20
-
-
84875017086
-
Androgen/androgen receptor pathway regulates expression of the genes for cyclooxygenase-2 and amphiregulin in periovulatory granulosa cells
-
10.1016/j.mce.2013.02.004, 23415714
-
Yazawa T, Kawabe S, Kanno M, Mizutani T, Imamichi Y, Ju Y, Matsumura T, Yamazaki Y, Usami Y, Kuribayashi M, Shimada M, Kitano T, Umezawa A, Miyamoto K. Androgen/androgen receptor pathway regulates expression of the genes for cyclooxygenase-2 and amphiregulin in periovulatory granulosa cells. Mol Cell Endocrinol 2013, 369:42-51. 10.1016/j.mce.2013.02.004, 23415714.
-
(2013)
Mol Cell Endocrinol
, vol.369
, pp. 42-51
-
-
Yazawa, T.1
Kawabe, S.2
Kanno, M.3
Mizutani, T.4
Imamichi, Y.5
Ju, Y.6
Matsumura, T.7
Yamazaki, Y.8
Usami, Y.9
Kuribayashi, M.10
Shimada, M.11
Kitano, T.12
Umezawa, A.13
Miyamoto, K.14
-
21
-
-
75949086226
-
Up-regulation of circadian clock gene Period 2 in the prostate mesenchymal cells during flutamide-induced apoptosis
-
10.1007/s11010-009-0238-7, 19714448
-
Yoshida K, He PJ, Yamauchi N, Hashimoto S, Hattori MA. Up-regulation of circadian clock gene Period 2 in the prostate mesenchymal cells during flutamide-induced apoptosis. Mol Cell Biochem 2010, 335:37-45. 10.1007/s11010-009-0238-7, 19714448.
-
(2010)
Mol Cell Biochem
, vol.335
, pp. 37-45
-
-
Yoshida, K.1
He, P.J.2
Yamauchi, N.3
Hashimoto, S.4
Hattori, M.A.5
-
22
-
-
84862909192
-
Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer
-
10.1016/j.cell.2011.11.026, 3266536, 22265403
-
Li Z, Tuteja G, Schug J, Kaestner KH. Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer. Cell 2012, 148:72-83. 10.1016/j.cell.2011.11.026, 3266536, 22265403.
-
(2012)
Cell
, vol.148
, pp. 72-83
-
-
Li, Z.1
Tuteja, G.2
Schug, J.3
Kaestner, K.H.4
-
23
-
-
84859043702
-
Activation of PKR/eIF2α signaling cascade is associated with dihydrotestosterone-induced cell cycle arrest and apoptosis in human liver cells
-
Dai R, Yan D, Li J, Chen S, Liu Y, Chen R, Duan C, Wei M, Li H, He T. Activation of PKR/eIF2α signaling cascade is associated with dihydrotestosterone-induced cell cycle arrest and apoptosis in human liver cells. J Cell Biochem 2012, 113:1800-1808.
-
(2012)
J Cell Biochem
, vol.113
, pp. 1800-1808
-
-
Dai, R.1
Yan, D.2
Li, J.3
Chen, S.4
Liu, Y.5
Chen, R.6
Duan, C.7
Wei, M.8
Li, H.9
He, T.10
-
24
-
-
0037105775
-
The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas
-
Lin L, Miller CT, Contreras JI, Prescott MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM, Glover TW, Beer DG. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res 2002, 62:5273-5279.
-
(2002)
Cancer Res
, vol.62
, pp. 5273-5279
-
-
Lin, L.1
Miller, C.T.2
Contreras, J.I.3
Prescott, M.S.4
Dagenais, S.L.5
Wu, R.6
Yee, J.7
Orringer, M.B.8
Misek, D.E.9
Hanash, S.M.10
Glover, T.W.11
Beer, D.G.12
-
25
-
-
79954568222
-
High-level expression of forkhead-box protein A1 in metastatic prostate cancer
-
10.1111/j.1365-2559.2011.03796.x, 21401706
-
Jain RK, Mehta RJ, Nakshatri H, Idrees MT, Badve SS. High-level expression of forkhead-box protein A1 in metastatic prostate cancer. Histopathology 2011, 58:766-772. 10.1111/j.1365-2559.2011.03796.x, 21401706.
-
(2011)
Histopathology
, vol.58
, pp. 766-772
-
-
Jain, R.K.1
Mehta, R.J.2
Nakshatri, H.3
Idrees, M.T.4
Badve, S.S.5
-
26
-
-
70349976819
-
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
-
10.1038/onc.2009.211, 3492882, 19617899
-
Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009, 28:3526-3536. 10.1038/onc.2009.211, 3492882, 19617899.
-
(2009)
Oncogene
, vol.28
, pp. 3526-3536
-
-
Coulouarn, C.1
Factor, V.M.2
Andersen, J.B.3
Durkin, M.E.4
Thorgeirsson, S.S.5
-
27
-
-
77950293595
-
Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer
-
10.1158/0008-5472.CAN-09-2979, 2831111, 20160041
-
Song Y, Washington MK, Crawford HC. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res 2010, 70:2115-2125. 10.1158/0008-5472.CAN-09-2979, 2831111, 20160041.
-
(2010)
Cancer Res
, vol.70
, pp. 2115-2125
-
-
Song, Y.1
Washington, M.K.2
Crawford, H.C.3
-
28
-
-
78651250284
-
FOXA1 is a key determinant of estrogen receptor function and endocrine response
-
10.1038/ng.730, 3024537, 21151129
-
Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet 2011, 43:27-33. 10.1038/ng.730, 3024537, 21151129.
-
(2011)
Nat Genet
, vol.43
, pp. 27-33
-
-
Hurtado, A.1
Holmes, K.A.2
Ross-Innes, C.S.3
Schmidt, D.4
Carroll, J.S.5
-
29
-
-
75449087853
-
Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis
-
Sano M, Aoyagi K, Takahashi H, Kawamura T, Mabuchi T, Igaki H, Tachimori Y, Kato H, Ochiai A, Honda H, Nimura Y, Nagino M, Yoshida T, Sasaki H. Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis. Int J Oncol 2010, 36:321-330.
-
(2010)
Int J Oncol
, vol.36
, pp. 321-330
-
-
Sano, M.1
Aoyagi, K.2
Takahashi, H.3
Kawamura, T.4
Mabuchi, T.5
Igaki, H.6
Tachimori, Y.7
Kato, H.8
Ochiai, A.9
Honda, H.10
Nimura, Y.11
Nagino, M.12
Yoshida, T.13
Sasaki, H.14
-
30
-
-
66649104862
-
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma
-
10.1158/1078-0432.CCR-08-3155, 19470727
-
Nucera C, Eeckhoute J, Finn S, Carroll JS, Ligon AH, Priolo C, Fadda G, Toner M, Sheils O, Attard M, Pontecorvi A, Nose V, Loda M, Brown M. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin Cancer Res 2009, 15:3680-3689. 10.1158/1078-0432.CCR-08-3155, 19470727.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3680-3689
-
-
Nucera, C.1
Eeckhoute, J.2
Finn, S.3
Carroll, J.S.4
Ligon, A.H.5
Priolo, C.6
Fadda, G.7
Toner, M.8
Sheils, O.9
Attard, M.10
Pontecorvi, A.11
Nose, V.12
Loda, M.13
Brown, M.14
-
31
-
-
84858997469
-
Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells
-
10.1111/j.1349-7006.2012.02201.x, 22313737
-
Abe Y, Ijichi N, Ikeda K, Kayano H, Horie-Inoue K, Takeda S, Inoue S. Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells. Cancer Sci 2012, 103:806-812. 10.1111/j.1349-7006.2012.02201.x, 22313737.
-
(2012)
Cancer Sci
, vol.103
, pp. 806-812
-
-
Abe, Y.1
Ijichi, N.2
Ikeda, K.3
Kayano, H.4
Horie-Inoue, K.5
Takeda, S.6
Inoue, S.7
-
32
-
-
84873743039
-
Insulin-like growth factor-I regulates GPER expression and function in cancer cells
-
10.1038/onc.2012.97, 22430216
-
De Marco P, Bartella V, Vivacqua A, Lappano R, Santolla MF, Morcavallo A, Pezzi V, Belfiore A, Maggiolini M. Insulin-like growth factor-I regulates GPER expression and function in cancer cells. Oncogene 2013, 32:678-688. 10.1038/onc.2012.97, 22430216.
-
(2013)
Oncogene
, vol.32
, pp. 678-688
-
-
De Marco, P.1
Bartella, V.2
Vivacqua, A.3
Lappano, R.4
Santolla, M.F.5
Morcavallo, A.6
Pezzi, V.7
Belfiore, A.8
Maggiolini, M.9
-
33
-
-
0031454203
-
Establishment of new epithelial carcinoma cell lines by blocking monolayer formation
-
10.1007/s004320050122, 9620227
-
Hackenberg R, Hawighorst T, Hild F, Schulz KD. Establishment of new epithelial carcinoma cell lines by blocking monolayer formation. J Cancer Res Clin Oncol 1997, 123:669-673. 10.1007/s004320050122, 9620227.
-
(1997)
J Cancer Res Clin Oncol
, vol.123
, pp. 669-673
-
-
Hackenberg, R.1
Hawighorst, T.2
Hild, F.3
Schulz, K.D.4
-
34
-
-
80053495697
-
MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo
-
10.1186/1471-2407-11-425, 3210504, 21970405
-
Jiang F, Liu T, He Y, Yan Q, Chen X, Wang H, Wan X. MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo. BMC Cancer 2011, 11:425. 10.1186/1471-2407-11-425, 3210504, 21970405.
-
(2011)
BMC Cancer
, vol.11
, pp. 425
-
-
Jiang, F.1
Liu, T.2
He, Y.3
Yan, Q.4
Chen, X.5
Wang, H.6
Wan, X.7
-
35
-
-
84887977769
-
The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness
-
Sisci D, Maris P, Cesario MG, Anselmo W, Coroniti R, Trombino GE, Romeo F, Ferraro A, Lanzino M, Aquila S, Maggiolini M, Mauro L, Morelli C, Andò S. The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness. Cell Cycle 2013, 12:3405-3420.
-
(2013)
Cell Cycle
, vol.12
, pp. 3405-3420
-
-
Sisci, D.1
Maris, P.2
Cesario, M.G.3
Anselmo, W.4
Coroniti, R.5
Trombino, G.E.6
Romeo, F.7
Ferraro, A.8
Lanzino, M.9
Aquila, S.10
Maggiolini, M.11
Mauro, L.12
Morelli, C.13
Andò, S.14
-
36
-
-
0037174891
-
The postmenopausal ovary as an androgen-producing gland; hypothesis on the etiology of endometrial cancer
-
10.1016/S0378-5122(02)00140-8, 12385855
-
Jongen VH, Sluijmer AV, Heineman MJ. The postmenopausal ovary as an androgen-producing gland; hypothesis on the etiology of endometrial cancer. Maturitas 2002, 43:77-85. 10.1016/S0378-5122(02)00140-8, 12385855.
-
(2002)
Maturitas
, vol.43
, pp. 77-85
-
-
Jongen, V.H.1
Sluijmer, A.V.2
Heineman, M.J.3
-
37
-
-
0037566592
-
The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients
-
10.1016/S0006-291X(03)00883-0, 12767946
-
Sasaki M, Sakuragi N, Dahiya R. The CAG repeats in exon 1 of the androgen receptor gene are significantly longer in endometrial cancer patients. Biochem Biophys Res Commun 2003, 305:1105-1108. 10.1016/S0006-291X(03)00883-0, 12767946.
-
(2003)
Biochem Biophys Res Commun
, vol.305
, pp. 1105-1108
-
-
Sasaki, M.1
Sakuragi, N.2
Dahiya, R.3
-
38
-
-
0028173314
-
Androgen regulation of the insulin-like growth factor-I and the estrogen receptor in rat uterus and liver
-
10.1016/0960-0760(94)90115-5, 7947351
-
Sahlin L, Norstedt G, Eriksson H. Androgen regulation of the insulin-like growth factor-I and the estrogen receptor in rat uterus and liver. J Steroid Biochem Mol Biol 1994, 51:57-66. 10.1016/0960-0760(94)90115-5, 7947351.
-
(1994)
J Steroid Biochem Mol Biol
, vol.51
, pp. 57-66
-
-
Sahlin, L.1
Norstedt, G.2
Eriksson, H.3
-
39
-
-
0033388099
-
An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA
-
10.1016/S1097-2765(00)80225-7, 10635321
-
Cirillo LA, Zaret KS. An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA. Mol Cell 1999, 4:961-969. 10.1016/S1097-2765(00)80225-7, 10635321.
-
(1999)
Mol Cell
, vol.4
, pp. 961-969
-
-
Cirillo, L.A.1
Zaret, K.S.2
-
40
-
-
23844485897
-
From the Cover: location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response
-
10.1073/pnas.0505575102, 1183449, 16087863
-
Laganière J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguère V. From the Cover: location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci U S A 2005, 102:11651-11656. 10.1073/pnas.0505575102, 1183449, 16087863.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 11651-11656
-
-
Laganière, J.1
Deblois, G.2
Lefebvre, C.3
Bataille, A.R.4
Robert, F.5
Giguère, V.6
-
41
-
-
70249128376
-
Functional enhancers at the gene-poor 8q24 cancer-linked locus
-
10.1371/journal.pgen.1000597, 2717370, 19680443
-
Jia L, Landan G, Pomerantz M, Jaschek R, Herman P, Reich D, Yan C, Khalid O, Kantoff P, Oh W, Manak JR, Berman BP, Henderson BE, Frenkel B, Haiman CA, Freedman M, Tanay A, Coetzee GA. Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet 2009, 5:e1000597. 10.1371/journal.pgen.1000597, 2717370, 19680443.
-
(2009)
PLoS Genet
, vol.5
-
-
Jia, L.1
Landan, G.2
Pomerantz, M.3
Jaschek, R.4
Herman, P.5
Reich, D.6
Yan, C.7
Khalid, O.8
Kantoff, P.9
Oh, W.10
Manak, J.R.11
Berman, B.P.12
Henderson, B.E.13
Frenkel, B.14
Haiman, C.A.15
Freedman, M.16
Tanay, A.17
Coetzee, G.A.18
-
42
-
-
35448991307
-
A study on Notch signaling in human breast cancer
-
Zang S, Ji Ch QX, Dong X, Ma D, Ye J, Ma R, Dai J, Guo D. A study on Notch signaling in human breast cancer. Neoplasma 2007, 54:304-310.
-
(2007)
Neoplasma
, vol.54
, pp. 304-310
-
-
Zang, S.1
Ji Ch, Q.X.2
Dong, X.3
Ma, D.4
Ye, J.5
Ma, R.6
Dai, J.7
Guo, D.8
-
43
-
-
33645473185
-
Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells
-
Wang Z, Zhang Y, Li Y, Banerjee S, Liao J, Sarkar FH. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 2006, 5:483-493.
-
(2006)
Mol Cancer Ther
, vol.5
, pp. 483-493
-
-
Wang, Z.1
Zhang, Y.2
Li, Y.3
Banerjee, S.4
Liao, J.5
Sarkar, F.H.6
-
44
-
-
25144523393
-
Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer
-
10.1158/1078-0432.CCR-05-0508, 16166416
-
Zorn KK, Bonome T, Gangi L, Chandramouli GV, Awtrey CS, Gardner GJ, Barrett JC, Boyd J, Birrer MJ. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res 2005, 11:6422-6430. 10.1158/1078-0432.CCR-05-0508, 16166416.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 6422-6430
-
-
Zorn, K.K.1
Bonome, T.2
Gangi, L.3
Chandramouli, G.V.4
Awtrey, C.S.5
Gardner, G.J.6
Barrett, J.C.7
Boyd, J.8
Birrer, M.J.9
-
45
-
-
58149388704
-
Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation
-
10.1002/jcp.21622, 18988190
-
Catalano S, Giordano C, Rizza P, Gu G, Barone I, Bonofiglio D, Giordano F, Malivindi R, Gaccione D, Lanzino M, De Amicis F, Andò S. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation. J Cell Physiol 2009, 218:490-500. 10.1002/jcp.21622, 18988190.
-
(2009)
J Cell Physiol
, vol.218
, pp. 490-500
-
-
Catalano, S.1
Giordano, C.2
Rizza, P.3
Gu, G.4
Barone, I.5
Bonofiglio, D.6
Giordano, F.7
Malivindi, R.8
Gaccione, D.9
Lanzino, M.10
De Amicis, F.11
Andò, S.12
-
46
-
-
0027941866
-
Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors
-
10.1002/ijc.2910590303, 7523316
-
Rutanen EM, Nyman T, Lehtovirta P, Ammälä M, Pekonen F. Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors. Int J Cancer 1994, 59:307-312. 10.1002/ijc.2910590303, 7523316.
-
(1994)
Int J Cancer
, vol.59
, pp. 307-312
-
-
Rutanen, E.M.1
Nyman, T.2
Lehtovirta, P.3
Ammälä, M.4
Pekonen, F.5
-
47
-
-
0035328703
-
Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN
-
Matsushima-Nishiu M, Unoki M, Ono K, Tsunoda T, Minaguchi T, Kuramoto H, Nishida M, Satoh T, Tanaka T, Nakamura Y. Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN. Cancer Res 2001, 61:3741-3749.
-
(2001)
Cancer Res
, vol.61
, pp. 3741-3749
-
-
Matsushima-Nishiu, M.1
Unoki, M.2
Ono, K.3
Tsunoda, T.4
Minaguchi, T.5
Kuramoto, H.6
Nishida, M.7
Satoh, T.8
Tanaka, T.9
Nakamura, Y.10
-
48
-
-
84866893040
-
Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer
-
10.1371/journal.pone.0046072, 3459846, 23029392
-
Huang KT, Pavlides SC, Lecanda J, Blank SV, Mittal KR, Gold LI. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer. PLoS One 2012, 7:e46072. 10.1371/journal.pone.0046072, 3459846, 23029392.
-
(2012)
PLoS One
, vol.7
-
-
Huang, K.T.1
Pavlides, S.C.2
Lecanda, J.3
Blank, S.V.4
Mittal, K.R.5
Gold, L.I.6
-
49
-
-
0035863402
-
Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study
-
Thigpen T, Brady MF, Homesley HD, Soper JT, Bell J. Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2001, 19:364-367.
-
(2001)
J Clin Oncol
, vol.19
, pp. 364-367
-
-
Thigpen, T.1
Brady, M.F.2
Homesley, H.D.3
Soper, J.T.4
Bell, J.5
-
50
-
-
61649124729
-
The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy
-
10.1111/j.1749-6632.2008.03677.x, 19250195
-
Day JM, Purohit A, Tutill HJ, Foster PA, Woo LW, Potter BV, Reed MJ. The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy. Ann N Y Acad Sci 2009, 1155:80-87. 10.1111/j.1749-6632.2008.03677.x, 19250195.
-
(2009)
Ann N Y Acad Sci
, vol.1155
, pp. 80-87
-
-
Day, J.M.1
Purohit, A.2
Tutill, H.J.3
Foster, P.A.4
Woo, L.W.5
Potter, B.V.6
Reed, M.J.7
|